Doherty, N. ., Cardwell, C. R., Murchie, P. ., Hill, C. ., Azoulay, L. ., & Hicks, B. . (2023). 5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-22-1109
L. Azoulay
First name
L.
Last name
Azoulay
Rouette, J. ., McDonald, E. G., Schuster, T. ., Brophy, J. M., & Azoulay, L. . (2022). Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. J Am Heart Assoc, 11, e026789. http://doi.org/10.1161/jaha.122.026789
Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380
Abrahami, D. ., Tesfaye, H. ., Yin, H. ., Vine, S. ., Hicks, B. ., H. Y. Yu, O. ., … Azoulay, L. . (2022). Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1174
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094
Suissa, K. ., Schneeweiss, S. ., Douros, A. ., Yin, H. ., Patorno, E. ., & Azoulay, L. . (2022). Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. Diabetes Res Clin Pract, 192, 110094. http://doi.org/10.1016/j.diabres.2022.110094
Pradhan, R. ., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2022). Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc22-0712
Abenhaim, H. A., Suissa, S. ., Azoulay, L. ., Spence, A. R., Czuzoj-Shulman, N. ., & Tulandi, T. . (2022). Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstet Gynecol, 139, 1103–1110. http://doi.org/10.1097/aog.0000000000004723
Rouette, J. ., McDonald, E. G., Schuster, T. ., Brophy, J. M., & Azoulay, L. . (2022). Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study. BMJ Open, 12, e057510. http://doi.org/10.1136/bmjopen-2021-057510
Khosrow-Khavar, F. ., Azoulay, L. ., Montastruc, J. L., Montastruc, F. ., & Renoux, C. . (2022). Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer. http://doi.org/10.1002/cncr.34208